Status:
UNKNOWN
Late Preterm Corticosteroids and Neonatal Hypoglycemia
Lead Sponsor:
University of Southern California
Conditions:
Neonatal Hypoglycemia
Prematurity
Eligibility:
FEMALE
Phase:
PHASE4
Brief Summary
This is a prospective randomized controlled trial investigating the timing of betamethasone administration in late preterm infants in relation to delivery and impact on neonatal hypoglycemia. Previous...
Detailed Description
The use of antenatal corticosteroids for women at risk for preterm delivery has become widely adopted as standard of care. The American College of Obstetrics and Gynecologists (ACOG) officially recomm...
Eligibility Criteria
Inclusion
- Singleton pregnancy
- Gestational age 34 0/7 weeks to 36 5/7 weeks
- Planned delivery in late preterm period
Exclusion
- Prior course of betamethasone during pregnancy
- Twin gestation
- Fetal demise
- Major fetal anomaly
- Maternal contraindication to betamethasone
- Pregestational diabetes
- Expected delivery within 12 hours of randomization
Key Trial Info
Start Date :
July 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT04869709
Start Date
July 1 2021
End Date
July 1 2024
Last Update
May 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LAC+USC Medical Center
Los Angeles, California, United States, 90033